Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus
Doing so can lead to a rebound effect, where your appetite and cravings return in full force, making it harder to maintain your weight loss progress
Any cloudiness, haziness, or milky appearance indicates protein aggregation
Curr Biol 22:R792793 Nakamura S, Karalay O, Jager PS, Horikawa M, Klein C, Nakamura K, Latza C, Templer SE, Dieterich C, Antebi A (2016) Mondo complexes regulate TFEB via TOR inhibition to promote longevity in response to gonadal signals
The studys unique geographical context, conducted in Australia, also adds valuable evidence to the global body of research, providing insights into how these medications may impact dementia risk in different healthcare and population settings